Penn Medicine Provider
Infectious Diseases
William R. Short, MD, MPH
5.0
(132)
Accepting new patients
Sees patients age 18 and up
Penn Infectious Diseases Penn Presbyterian

About me

  • Associate Professor of Clinical Medicine (Infectious Diseases)
  • Associate Professor of Clinical Medicine in Obstetrics and Gynecology

Education and training

  • Medical School: Hahnemann University School of Medicine
  • Residency: Hahnemann University Hospital
  • Fellowship: Hahnemann University Hospital

What my patients think about me

Average Rating
5.0

132 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
excellent quality of care
March 2025
5.0
5.0
dr short is amazing he's one of the best
March 2025
5.0
5.0
dr. short is a miracle worker!
March 2025
5.0
5.0
his professionalism and great character thank you dr.short

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Short is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Zapata Vaca M, Tsosie CR, Logue-Chamberlain E, Coutifaris P, Christensen T, Mabry AB, Mohamed O, Tedaldi E, Oliver EA, Short WR, Lowenthal ED "My body my baby": a qualitative study examining drivers of infant-feeding choices among women living with HIV in Philadelphia, United States , AIDS Care: 2025,Epub ahead of print


Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related Weight Gain , Clinical Infectious Diseases, 80(3): 2025,602-612


Richterman A, Aitcheson N, Durnwald C, Curley C, Short WR, Jean Louis M, Momplaisir F, Thirumurthy H. Mental Bandwidth is Associated with HIV and Viral Suppression Among Low-Income Women in Philadelphia , AIDS Behavior, 29(2): 2025,556-561


Mantas S, O'Bryan J, Giles ML, Short WR, Logue-Chamberlain E, Krishnaswamy S Barriers to Clinician Reporting to the Antiretroviral Pregnancy Registry From Within and Outside the United States , Open Forum Infectious Diseases, 12(2): 2025,ofaf023


Meanley S, Carter WB, Short WR, Metzger DS, Anorato A, Montaner LJ, Dube K HIV Clinical Providers’ Awareness, Attitudes, and Willingness to Support Patient Outreach Efforts for HIV Cure–Directed Research in Philadelphia, United States , Open Forum Infectious Diseases, 11(12): 2024,ofae687


Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, Pérez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy , Pharmacotherapy, 44(5): 2024,360-382


Gandhi M, Hill L, Grochowski J, Nelson A, Koss CA, Mayorga-Munoz F, Oskarsson J, Shiels M, Avery A, Bamford L, Baron J, Short WR, Hileman CO Case Series of People with HIV on the Long-Acting Combination of Lenacapravir and Cabotegravir: Call for a Trial , Open Forum Infectious Diseases, 11(4): 2024,ofae 125


Holt LM, Short WR, Momplaisir F, Hyun E, McKinney J, Morales AL, Duque A, Druyan B, Ndubizu C, Duthely L, Joseph N, Sheth A, Badell ML. Bictegravir use during pregnancy: a multi-center retrospective analysis evaluating HIV viral suppression and perinatal outcomes , Clinical Infectious Diseases: 2024


Paules CI, Wang J, Tomashek KM, Bonnett T, Singh K, Marconi VC, Davey RT, Lye DC, Dodd LE, Yang OO, Benson CA, Deye GA, Doernberg SB, Hynes NA, Grossberg R, Wolfe CR, Nayak SU, Short WR, Voell J, Potter GE, Rapaka RR. A Risk Profile Driven by Simple Hematologic Parameters Predicts Differential Benefit from Baricitinib in Hospitalized COVID-19 Patients: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2 , Annals of Internal Medicine , 177(3): 2024,343-352


Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials , EClinicalMedicine, 9(69): 2024,102472